ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

Characteristics of the organization of medical care for in vitro fertilization programs in the Russian Federation and the European Union

Galitsyna E.V., Ulyakina N.A.

Russian Research Institute of Health, Moscow, Russia

Background: One of the main reasons for the decline in demographic indicators in European countries and the Russian Federation is infertility. In this regard, providing high-quality medical care to patients with infertility through government-funded assisted reproductive technologies (ART) is of great social importance.
Objective: To compare the organization of medical care for ART in Russia and European countries.
Materials and methods: The characteristics of the medical care organization in Russia and other European countries were compared according to the selected criteria indicated as reference in the European Atlas of Fertility Treatment Policies.
Results: The article discusses the characteristics of the current legal documents regulating the use of ART, the organization of medical psychological support, as well as scientific literature and statistical data on in vitro fertilization (IVF) program implementation in the Russian Federation. To analyze the policy on the use of ART in European countries, the analytical review data and information provided in the European Atlas of Fertility Treatment Policies are considered. The similarities and differences in the organization of medical care for ART in Russia and European countries have been identified.
Conclusion: The analysis revealed that ART programs in most European countries and Russia are financed from public funds. However, there are some differences in the availability of IVF procedures depending on the patient’s age, intrauterine insemination services, medical psychological support, preimplantation genetic testing, as well as waiting time for IVF procedures and different gamete donation policies.

Authors’ contributions: Galitsyna E.V. – formulation of the concept and conclusions of the study, collection, analysis and interpretation of literature data, writing and critical revision of the manuscript; Ulyakina N.A. – formulation of the conclusions of the study, substantiating the theoretical and practical significance of the work, editing and approving the final version of the manuscript for publication.
Conflicts of interest: Authors declare lack of the possible conflicts of interest.
Funding: The study was conducted with the financial support of the Ministry of Health of the Russian Federation aimed at ensuring the activities of the Coordination Center for Research and Development in Health of the Russian Research Institute of Health.
Ethical Approval: This type of research does not require an expert assessment from a local ethics committee.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Galitsyna E.V., Ulyakina N.A. Characteristics of the organization of medical care for 
in vitro fertilization programs in the Russian Federation and the European Union.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (12): 145-153 (in Russian) 
https://dx.doi.org/10.18565/aig.2025.275

Keywords

compulsory medical insurance (CMI)
assisted reproductive technologies (ART)
in vitro fertilization (IVF)
intracytoplasmic sperm injection (ICSI)
intrauterine insemination
anti-Müllerian hormone

References

  1. Русанова Н.Е. Влияние вспомогательной репродукции на самосохранительное поведение населения. Социальные аспекты здоровья населения. 2024; 70(4): 7. [Rusanova N.E. The impact of assisted reproduction on self-preservation behavior of the population. Social aspects of population health. 2024; 70(4): 7 (in Russian)]. https://dx.doi.org/10.21045/2071-5021-2024-70-4-7
  2. ESHRE. Factsheet on infertility – prevalence, treatment and fertility decline in Europe. Available at: https://www.eshre.eu/Press-Room/Resources/Fact-sheets (accessed September 26, 2025).
  3. Smeenk J., Wyns C., De Geyter C., Kupka M., Bergh C., Cuevas Saiz I. et al. ART in Europe, 2019: results generated from European registries by ESHRE. Hum. Reprod. 2023; 38(12): 2321-38. https://dx.doi.org/10.1093/humrep/dead197
  4. Российская Aссоциация Репродукции человека. Регистр ВРТ. Отчет за 2019 год. Доступно по: https://www.rahr.ru/d_registr_otchet/RegistrART2019.pdf (дата доступа: 26.09.2025). [Russian Association of Human Reproduction. ART register. 2019 report. Available at: https://www.rahr.ru/d_registr_otchet/RegistrART2019.pdf (accessed September 25, 2025) (in Russian)].
  5. Fertility Europe. Atlas of fertility treatment policies in Europe in 2024. Available at: https://fertilityeurope.eu/atlas2024/
  6. Fertility Europe. Atlas of fertility treatment policies in Europe in 2021. Available at: https://fertilityeurope.eu/atlas/
  7. Calhaz-Jorge C., De Geyter C.H., Kupka M.S., Wyns C., Mocanu E., Motrenko T. et al. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: the European IVF-monitoring consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum. Reprod. 2020; 2020(1): hoz044. https://dx.doi.org/10.1093/hropen/hoz044
  8. ESHRE fact sheets, 4 January 2017. The funding of IVF treatment. Available at: https://www.eshre.eu/-/media/sitecore-files/Press-room/Resources/4-Reimbursement.pdf
  9. Bayefsky M.J. Comparative preimplantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism. Reprod. Biomed. Soc. Online. 2016; 3: 41-7. https://dx.doi.org/10.1016/j.rbms.2017.01.001
  10. Приказ Министерства здравоохранения РФ от 31 июля 2020 г. № 803н «О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и ограничениях к их применению». Доступно по: https://www.garant.ru/products/ipo/prime/doc/74676088/ [Order of the Ministry of Health of the Russian Federation No. 803n dated July 31, 2020. "On the procedure for using assisted reproductive technologies, contraindications, and restrictions on their use". Available at: https://www.garant.ru/products/ipo/prime/doc/74676088/ (in Russian)].
  11. Центр репродукции «Линия жизни». До какого возраста делают ЭКО? Доступно по: https://life-reproduction.ru/stat-i/do-kakogo-vozrasta-delayut-eko/ (дата доступа: 26.09.2025).[Reproduction center "Life line". At what age is IVF performed? Available at: https://life-reproduction.ru/stat-i/do-kakogo-vozrasta-delayut-eko/ (accessed: September 25, 2025). (in Russian)].
  12. Счетная палата Российской Федерации. Отчет о результатах экспертно-аналитического мероприятия. Анализ эффективности расходования средств обязательного медицинского страхования в 2019 году и истекшем периоде 2020 года при проведении процедуры экстракорпорального оплодотворения. Доступно по: https://opis-cdn.tinkoffjournal.ru/mercury/otchet-eco.pdf (дата доступа: 26.09.2025). [The Accounts Chamber of the Russian Federation. Report on the results of an expert and analytical event. Analysis of the effectiveness of spending mandatory health insurance funds in 2019 and the expired period of 2020 during the in vitro fertilization procedure. Available at: https://opis-cdn.tinkoffjournal.ru/mercury/otchet-eco.pdf (accessed: September 25, 2025). (in Russian)].
  13. Постановление Правительства РФ от 28 декабря 2023 г. № 2353 «О Программе государственных гарантий бесплатного оказания гражданам медицинской помощи на 2024 год и на плановый период 2025 и 2026 годов». Доступно по: http://government.ru/docs/all/151778/ [Decree of the Government of the Russian Federation No. 2353 dated December 28, 2023 "On the Program of state guarantees for free medical care for citizens for 2024 and the planning period of 2025 and 2026". Available at: http://government.ru/docs/all/151778/ (in Russian)].
  14. Выскочков В.С., Бузин В.Н. Показатели динамики численности медицинских психологов вмедицинских организациях за 20 лет (2004–2024 гг.). Социальные аспекты здоровья населения. 2024; 70(S5): 13. [Vyskochkov V.S., Buzin V.N. Indicators of the dynamics of the number of medical psychologists in medical organizations over 20 years (2004–2024). Social aspects of population health. 2024; 70(S5): 13 (in Russian)]. https://dx.doi.org/10.21045/2071-5021-2024-70-5S-13
  15. De Rycke M., Berckmoes V., De Vos A., Van De Voorde S., Verdyck P., Verpoest W. et al. Preimplantation genetic testing: clinical experience of preimplantation genetic testing. Reproduction. 2020; 160(5): A45-58. https://dx.doi.org/10.1530/REP-20-0082
  16. Genetico. Выбор пола при проведении ПГТ. Доступно по: https://genetico.ru/stati/pgt-v-mire.html (дата доступа 26.09.2025). [Genetico. Sex selection during PGT. Available at: https://genetico.ru/stati/pgt-v-mire.html (accessed: September 25, 2025). (in Russian)].
  17. Ginoza M.E.C., Isasi R. Regulating preimplantation genetic testing across the world: a comparison of international policy and ethical perspectives. Cold Spring Harb. Perspect. Med. 2020; 10(5): a036681. https://dx.doi.org/10.1101/cshperspect.a036681
  18. Alon I., Bussod I., Ravitsky V. Mapping ethical, legal, and social implications (ELSI) of preimplantation genetic testing (PGT). J. Assist. Reprod. Genet. 2024; 41(5): 1153-71. https://dx.doi.org/10.1007/s10815-024-03076-y
  19. Чоговадзе А.Г. Особенности законодательного регулирования преимплантационной и пренатальной генетической диагностики в различных странах. Гены и клетки. 2012; 7(2): 112-8. [Chogovadze A.G. Features of legislative regulation of preimplantation and prenatal genetic diagnosis in different countries. Genes and Cells. 2012; 7(2): 112-8 (in Russian)].
  20. Yang H., DeWan A.T., Desai M.M., Vermund S.H. Preimplantation genetic testing for aneuploidy: challenges in clinical practice. Hum. Genomics. 2022; 16(1): 69. https://dx.doi.org/10.1186/s40246-022-00442-8
  21. EurekAlert. Europe moves towards complete statutory regulation of ART. But large variations still exist in how the legislation is applied. Peer-Reviewed Publication. European Society of Human Reproduction and Embryology. Available at: https://www.eurekalert.org/news-releases/895168
  22. Министерство здравоохранения Российской Федерации. Федеральный закон от 21.11.2011 № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации. Доступно по: https://minzdrav.gov.ru/documents/7025 [Ministry of Health of the Russian Federation. Federal Law No. 323-FZ dated November 21, 2011 "On the fundamentals of protecting the health of citizens in the Russian Federation. Available at: https://minzdrav.gov.ru/documents/7025 (in Russian)].
  23. Благотворительный фонд «Свет в руках». Профилактика и лечение бесплодия. Доступно по: https://lightinhands.ru/program/profilaktika-i-lechenie-besplodiya/ (дата доступа: 26.09.2025). [Charity Foundation "Light in Hands". Prevention and Treatment of Infertility. Available at: https://lightinhands.ru/program/profilaktika-i-lechenie-besplodiya/ (accessed: September 25, 2025) (in Russian)].
  24. ГК «Протек». Программа по преодолению бесплодия «Новая жизнь». Доступно по: https://xn--80aafj2agk3g.xn--p1ai/storage/2023/05/16/f4e0d3307146bac643b3b7dd9440832bfc6acb8d.pdf (дата доступа: 26.09.2025). [«Protek» Group of Companies. Infertility treatment program "New life". Available at: https://xn--80aafj2agk3g.xn--p1ai/storage/2023/05/16/f4e0d3307146bac643b3b7dd9440832bfc6acb8d.pdf (accessed: September 25, 2025) (in Russian)].
  25. Скандинавия АВА-ПЕТЕР. Миф об ЭКО: процедуру назначают женщинам только после 35 лет. Доступно по: https://avapeter.ru/clients/blog/mif-ob-eko-protseduru-naznachayut-zhenshchinam-tolko-posle-35-let/ (дата доступа: 26.09.2025) [Scandinavia AVA-PETER. The myth about IVF: the procedure is prescribed to women only after 35 years. Available at: https://avapeter.ru/clients/blog/mif-ob-eko-protseduru-naznachayut-zhenshchinam-tolko-posle-35-let/ (accessed: September 26, 2025) (in Russian)].
  26. АО «Группа Компаний «Медси». Пространство здоровья. До какого возраста можно делать ЭКО? Доступно по: https://medsi.ru/articles/do-kakogo-vozrasta-mozhno-delat-eko/ (дата доступа: 26.09.2025). [JSC "Group of Companies "Medsi". The health space. At what age can IVF be done? Available at: https://medsi.ru/articles/do-kakogo-vozrasta-mozhno-delat-eko/ (accessed: September 26, 2025) (in Russian)].
  27. Бузин В.Н., Бузина Т.С. Оценка населением доступности психологической помощи: социологическое исследование. Социальные аспекты здоровья населения. 2022; 68(1): 13. [Buzin V.N., Buzina T.S. Assessment of psychological care availability by the population: a sociological study. Social aspects of population health. 2022; 68(1): 13 (in Russian)]. https://dx.doi.org/10.21045/2071-5021-2022-68-1-13
  28. Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Министерства здравоохранения Российской Федерации. Донорство (для доноров спермы, для доноров ооцитов). Доступно по: https://ncagp.ru/index.php?_t8=621 (дата доступа: 26.09.2025). [Federal State Budgetary Institution "National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov" of the Ministry of Health of the Russian Federation. Donorship (for sperm donors, for oocyte donors). Available at: https://ncagp.ru/index.php?_t8=621 (accessed: September 26, 2025) (in Russian)].
  29. Tulandi T., King L., Zelkowitz P. Public funding of and access to in vitro fertilization. N. Engl. J. Med. 2013; 368(20): 1948-9. https://dx.doi.org/10.1056/NEJMc1213687

Received 30.09.2025

Accepted 12.12.2025

About the Authors

Elena V. Galitsyna, PhD (Biology), Leading specialist of the Project Support Department of the Coordination Center for Research and Development in the Field of Medical Science, Russian Research Institute of Health, Moscow, galitsynaev@mednet.ru, https://orcid.org/0000-0003-2305-4936
Natalya A. Ulyakina, PhD (Pedagogical), Head of the Project Support Department of the Coordination Center for Research and Development in the Field of Medical Science, Russian Research Institute of Health, Moscow, ulyakinana@mednet.ru, https://orcid.org/0000-0003-0187-1898
Corresponding author: Elena V. Galitsyna, galitsynaev@mednet.ru

Similar Articles